in study 1 , ie ( ifosfamide , 1.5 g/m2 , days 1 through 5 ; etoposide , 120 mg/m2 , days 3 through 5 ) alternating with cav ( cyclophosphamide , 600 mg/m2 , days 1 and 2 ; doxorubicin , 50 mg/m2 , day 1 ; vincristine , 2 mg , day 1 ) was compared with a response-oriented treatment with ie therapy up to maximum response and subsequently an immediate switch to cav .
C0020823
ifosfamide
C0010583
cyclophosphamide